JP Morgan Maintains Neutral on Haemonetics, Raises Price Target to $86

Benzinga · 1d ago
JP Morgan analyst Allen Gong maintains Haemonetics (NYSE:HAE) with a Neutral and raises the price target from $62 to $86.